Je. Hoppe et al., RETROSPECTIVE ANALYSIS OF YEAST COLONIZATION AND INFECTIONS IN PEDIATRIC BONE-MARROW TRANSPLANT RECIPIENTS, Mycoses, 40(1-2), 1997, pp. 47-54
Sixty-four pediatric patients who underwent allogeneic (n = 35), autol
ogous (n = 28) or syngeneic (n = 1) bone marrow transplantation (BMT)
between 1992 and 1994 were evaluated retrospectively. As antifungal pr
ophylaxis, all patients received amphotericin B tablets and 62 of 64 (
96.9%) received oral fluconazole. Weekly surveillance cultures reveale
d fungal colonization in 35 patients (54.7%). Six patients (9.4%) were
colonized before BMT only, 17 (26.6%) after BMT only and 12 (18.8%) b
oth before and after BMT. Candida albicans was the most frequently iso
lated fungus [21 of 46 fungal isolates (45.7%)], followed by C. glabra
ta [14 isolates (30.4%)]. Non-albicans species of Candida were most fr
equently isolated after BMT from the faeces, often in high numbers. Au
tologous marrow recipients had a higher fungal colonization rate both
before and after BMT than allogeneic marrow recipients. One patient su
ffered from invasive pulmonary aspergillosis after BMT. No fungaemis o
r deep-seated yeast infections were observed. Six of the seven patient
s who had to be treated with intravenous amphotericin B because of ant
ibiotic-refractory fever had undergone autologous BMT. Multivariate an
alysis of various parameters showed only pre-BMT yeast colonization to
be independently associated with post-BMT colonization. Thus, systemi
c mycoses occurred only rarely in this study population; however yeast
colonization after BMT (especially with non-albicans species) was a f
requent in spite of double prophylaxis with oral amphotericin B and fl
uconazole.